1
FORM 3 U.S. SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
FILED PURSUANT TO SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934, SECTION
17(a) OF THE PUBLIC UTILITY HOLDING COMPANY ACT OF 1935 OR SECTION 30(f) OF THE
INVESTMENT COMPANY ACT OF 1940
1. Name and Address of Reporting Person 2. Date of Event 4. Issuer Name and Ticker or Trading Symbol
Requiring Statement
Abbott Laboratories (Month/Day/Year) i-STAT Corporation (NASDAQ: STAT)
08/03/98
(Last) (First) (Middle)
3. IRS Identification 5. Relationship of Reporting Person to Issuer
c/o Abbott Laboratories, 100 Abbott Park Road Number of Reporting (Check all applicable)
Dept. 0323, Bldg. AP6D2 Person, if an Entity Director X 10% Owner
(Voluntary) ----- -------
(Street) Officer Other
36-0698440 ----- --------
Abbott Park Illinois 60064-3500 (give title (specify
(City) (State) (Zip) below) below)
6. If Amendment, Date of Original
(Month/Day/Year)
7. Individual or Joint/Group Filing
(Check applicable)
___X___Form Filed by One
Reporting Person
______Form filed by More than One
Reporting Person
TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect Beneficial Ownership
(Instr. 4) Beneficially Owned Direct (D) or Indirect (I) (Instr. 4)
(Instr. 4) (Instr. 5)
Common Stock,
par value $0.15 per share 0 D
*If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. (Print or Type Responses)
(Over)
2
FORM 3 (CONTINUED)TABLE II -- DERIVATIVE SECURITIES BENEFICALLY OWNED (E.G.,
PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
1. Title of Derivative 2. Date Exer- 3. Title and Amount of 4.Conver- 5.Owner- 6.Nature of Indirect
Security(Instr. 4) cisable and Securities Underlying sion or ship Beneficial Ownership
Expiration Derivative Security Exercise Form of (Instr. 5)
Date (Instr. 4) Price of Deriv-
(Month/Day/ Deri- ative
vative Security:
Security Direct
(D) or
Indirect
(I)
(Instr. 5)
Date Expira- Amount
Exer- tion or
cisable Date Title Number
of
Shares
None
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Miles D. White, Executive Vice President, on behalf of Abbott Laboratories
- -------------------------------------------------------------------------------
**Signature of Reporting Person
08/12/1998
----------
Date
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, See Instruction 6 for procedure.
Page 2
